PubMed Summary

Title Average Ratingsort ascending
Chemoradiotherapy in malignant glioma: standard of care and future directions. 50.00%
Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-Km catalysts of cyclophosp 50.00%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. 50.00%
Inhibition of angiogenesis of LCI-D20 hepatocellular carcinoma by metronomic chemotherapy of S-1 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Tumoral angiogenesis: review of the literature. 50.00%
Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. 40.00%
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts. 40.00%
Ependymoma. 40.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Ukrain treatment of rhabdomyosarcoma (case report) 40.00%
Inhibition of MIF Leads to Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells. 40.00%
Ukrain: acute toxicity after intravenous, intramuscular and oral administration in rats 40.00%
Phase II study of calcitriol-enhanced docetaxel in patients with previously untreated metastatic or locally advanced pancreatic 40.00%
Pancreatic cancer stem cells - insights and perspectives. 40.00%
In vitro and in vivo antiproliferative activity of laherradurin and cherimolin-2 of Annona diversifolia Saff. 40.00%
Enhancement of macrophage tumouricidal activity by the alkaloid derivative 40.00%
Gemcitabine combined with uracil-tegafur in patients with advanced pancreatic cancer. 40.00%
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. 40.00%
Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer. 40.00%
Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplat 40.00%
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. 40.00%
Long term outcomes following surgical resection of myxopapillary ependymomas. 40.00%
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. 35.00%
Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. 30.00%
Management of the patient and family with neurofibromatosis 2: a consensus conference statement. 30.00%
Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice. 30.00%
The influence of Ukrain on the growth of HA-1 tumor in mice: the role of cysteine proteinases as markers of tumor malignancy 30.00%
A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followe 30.00%
Cysteine proteinase inhibitor level in tumor and normal tissues in control and cured mice. 30.00%
Six-week treatment with Ukrain in rabbits. Part II: Serum levels of gonadal hormones 20.00%
Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer. 20.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
Removed because of suspicion of scientific fraud: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. 10.00%
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. 0.00%
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer........ 0.00%
Effect of Ukrain on human liver alcohol dehydrogenase activity in vitro. 0.00%
Teratological evaluation of Ukrain in hamsters and rats 0.00%
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud 0.00%
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. 0.00%
Improved prognosis of postoperative hepatocellular carcinoma patients when treated with functional foods: a prospective cohort s 0.00%
Preliminary pharmacokinetic studies of Ukrain in rats 0.00%
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhib 0.00%
Six-week treatment with Ukrain in rabbits. Part III: Serum levels of thyroid hormones 0.00%
Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative.... 0.00%

Pages